Related references
Note: Only part of the references are listed.Iron in arterial plaque: A modifiable risk factor for atherosclerosis
Jerome L. Sullivan
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2009)
Cyclooxygenase-2 inhibition increases lipopolysaccharide-induced atherosclerosis in mice
Jonathan M. Gitlin et al.
CARDIOVASCULAR RESEARCH (2009)
Insights Into the Role of Infection in Atherogenesis and in Plaque Rupture
Stephen E. Epstein et al.
CIRCULATION (2009)
Genetic deficiency of NADPH oxidase does not diminish, but rather enhances, LPS-induced acute inflammatory responses in vivo
Wei-Jian Zhang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Antiinflammatory and antiatherogenic effects of the NF-κB inhibitor acetyl-11-keto-β-boswellic acid in LPS-challenged ApoE-/- mice
Clarisse Cuaz-Perolin et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Can iron chelators influence the progression of atherosclerosis?
Joannes J. M. Marx et al.
HEMOGLOBIN (2008)
Apolipoprotein C-I is crucially involved in lipopolysaccharide-induced atherosclerosis development in apolipoprotein E-knockout mice
Marit Westerterp et al.
CIRCULATION (2007)
A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance
M. A. Tanner et al.
CIRCULATION (2007)
Reduction of iron stores and cardiovascular outcomes in patients with peripheral arterial disease - A randomized controlled trial
Leo R. Zacharski et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Iron chelation inhibits NF-κB-mediated adhesion molecule expression by inhibiting p22phox protein expression and NADPH oxidase activity
Lixin Li et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
The iron chelator desferrioxamine inhibits atherosclerotic lesion development and decreases lesion iron concentrations in the cholesterol-fed rabbit
MQ Ren et al.
FREE RADICAL BIOLOGY AND MEDICINE (2005)
Iron loading increases cholesterol accumulation and macrophage scavenger receptor I expression in THP-1 mononuclear phagocytes
PJ Kraml et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2005)
Iron metabolism and toxicity
G Papanikolaou et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2005)
Intracellular labile iron modulates adhesion of human monocytes to human endothelial cells
AER Kartikasari et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Role of oxidative modifications in atherosclerosis
R Stocker et al.
PHYSIOLOGICAL REVIEWS (2004)
Direct detection and quantification of transition metal ions in human atherosclerotic plaques: Evidence for the presence of elevated levels of iron and copper
N Stadler et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Endosomal and lysosomal effects of desferrioxamine: Protection of HeLa cells from hydrogen peroxide-induced DNA damage and induction of cell-cycle arrest
PT Doulias et al.
FREE RADICAL BIOLOGY AND MEDICINE (2003)
Intracellular metal ion chelators inhibit TNFα-induced Sp-1 activation and adhesion molecule expression in human aortic endothelial cells
WJ Zhang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2003)
In vivo evidence for a role of toll-like receptor 4 in the development of intimal lesions
A Vink et al.
CIRCULATION (2002)
Implication of natural killer T cells in atherosclerosis development during a LPS-induced chronic inflammation
MA Ostos et al.
FEBS LETTERS (2002)
Deleterious iron-mediated oxidation of biomolecules
KD Welch et al.
FREE RADICAL BIOLOGY AND MEDICINE (2002)
Iron overload diminishes atherosclerosis in apoE-deficient mice
EA Kirk et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Share Paper
